Cencora Gross Margin 2010-2024 | COR
Current and historical gross margin for Cencora (COR) over the last 10 years. The current gross profit margin for Cencora as of September 30, 2024 is %.
| Cencora Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $293.96B | $9.91B | 3.37% |
| 2024-06-30 | $283.83B | $9.67B | 3.41% |
| 2024-03-31 | $276.54B | $9.53B | 3.44% |
| 2023-12-31 | $271.58B | $9.28B | 3.42% |
| 2023-09-30 | $262.17B | $8.96B | 3.42% |
| 2023-06-30 | $254.43B | $8.69B | 3.42% |
| 2023-03-31 | $247.54B | $8.44B | 3.41% |
| 2022-12-31 | $241.81B | $8.38B | 3.47% |
| 2022-09-30 | $238.59B | $8.30B | 3.48% |
| 2022-06-30 | $236.33B | $8.38B | 3.55% |
| 2022-03-31 | $229.67B | $8.25B | 3.59% |
| 2021-12-31 | $221.10B | $7.55B | 3.41% |
| 2021-09-30 | $213.99B | $6.94B | 3.24% |
| 2021-06-30 | $204.32B | $6.22B | 3.04% |
| 2021-03-31 | $196.28B | $5.56B | 2.83% |
| 2020-12-31 | $194.55B | $5.41B | 2.78% |
| 2020-09-30 | $189.90B | $5.19B | 2.73% |
| 2020-06-30 | $186.29B | $5.03B | 2.70% |
| 2020-03-31 | $186.16B | $5.04B | 2.70% |
| 2019-12-31 | $182.06B | $5.07B | 2.79% |
| 2019-09-30 | $179.59B | $5.14B | 2.86% |
| 2019-06-30 | $177.25B | $4.99B | 2.81% |
| 2019-03-31 | $175.15B | $4.97B | 2.84% |
| 2018-12-31 | $172.87B | $4.80B | 2.78% |
| 2018-09-30 | $167.94B | $4.61B | 2.75% |
| 2018-06-30 | $163.76B | $4.75B | 2.90% |
| 2018-03-31 | $159.33B | $4.62B | 2.90% |
| 2017-12-31 | $155.44B | $4.62B | 2.97% |
| 2017-09-30 | $153.14B | $4.55B | 2.97% |
| 2017-06-30 | $151.58B | $4.50B | 2.97% |
| 2017-03-31 | $149.76B | $4.53B | 3.02% |
| 2016-12-31 | $148.31B | $4.35B | 2.93% |
| 2016-09-30 | $146.85B | $4.27B | 2.91% |
| 2016-06-30 | $144.76B | $4.12B | 2.85% |
| 2016-03-31 | $142.11B | $3.91B | 2.75% |
| 2015-12-31 | $139.08B | $3.74B | 2.69% |
| 2015-09-30 | $135.96B | $3.53B | 2.60% |
| 2015-06-30 | $132.08B | $3.43B | 2.60% |
| 2015-03-31 | $128.20B | $3.23B | 2.52% |
| 2014-12-31 | $123.98B | $3.05B | 2.46% |
| 2014-09-30 | $119.57B | $2.98B | 2.49% |
| 2014-06-30 | $112.45B | $2.68B | 2.38% |
| 2014-03-31 | $104.01B | $2.55B | 2.45% |
| 2013-12-31 | $96.08B | $2.54B | 2.64% |
| 2013-09-30 | $87.96B | $2.51B | 2.85% |
| 2013-06-30 | $82.23B | $2.64B | 3.21% |
| 2013-03-31 | $79.65B | $2.75B | 3.45% |
| 2012-12-31 | $78.83B | $2.71B | 3.44% |
| 2012-09-30 | $78.08B | $2.64B | 3.37% |
| 2012-06-30 | $78.23B | $2.47B | 3.16% |
| 2012-03-31 | $79.07B | $2.46B | 3.11% |
| 2011-12-31 | $79.12B | $2.46B | 3.11% |
| 2011-09-30 | $78.70B | $2.46B | 3.12% |
| 2011-06-30 | $79.35B | $2.48B | 3.13% |
| 2011-03-31 | $78.79B | $2.42B | 3.07% |
| 2010-12-31 | $78.33B | $2.34B | 2.99% |
| 2010-09-30 | $77.78B | $2.32B | 2.99% |
| 2010-06-30 | $76.96B | $2.30B | 2.99% |
| 2010-03-31 | $75.75B | $2.23B | 2.95% |
| 2009-12-31 | $73.76B | $2.17B | 2.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $47.484B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $91.424B | 11.34 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| Natera (NTRA) | United States | $21.401B | 0.00 |
| ICON (ICLR) | Ireland | $16.136B | 14.37 |
| Viatris (VTRS) | United States | $15.576B | 4.80 |
| Avantor (AVTR) | United States | $13.422B | 20.12 |
| Revvity (RVTY) | United States | $13.376B | 23.24 |
| CochLear (CHEOY) | Australia | $12.844B | 0.00 |
| BioMerieux (BMXMF) | France | $12.666B | 0.00 |
| Solventum (SOLV) | United States | $11.583B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.789B | 27.58 |
| Doximity (DOCS) | United States | $9.620B | 56.63 |
| Charles River Laboratories (CRL) | United States | $9.516B | 18.39 |
| HealthEquity (HQY) | United States | $8.966B | 48.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.758B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.885B | 32.05 |
| Life Times (LTH) | United States | $5.085B | 33.66 |
| Sotera Health (SHC) | United States | $3.855B | 20.62 |
| Organon (OGN) | United States | $3.757B | 3.79 |
| BrightSpring Health Services (BTSG) | United States | $3.247B | 69.07 |
| Surgery Partners (SGRY) | United States | $2.892B | 32.97 |
| PACS (PACS) | United States | $2.606B | 0.00 |
| Concentras Parent (CON) | United States | $2.581B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.375B | 0.00 |
| Premier (PINC) | United States | $2.143B | 11.15 |
| Alignment Healthcare (ALHC) | United States | $2.126B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.952B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.616B | 42.40 |
| Teladoc Health (TDOC) | United States | $1.537B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.255B | 12.28 |
| CareDx (CDNA) | United States | $1.183B | 0.00 |
| Progyny (PGNY) | United States | $1.164B | 23.57 |
| Establishment Labs Holdings (ESTA) | $1.050B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.954B | 6.46 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Embecta (EMBC) | United States | $0.778B | 5.18 |
| SBC Medicals (SBC) | United States | $0.677B | 0.00 |
| Agilon Health (AGL) | United States | $0.655B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.647B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.536B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.425B | 0.00 |
| DocGo (DCGO) | United States | $0.410B | 15.46 |
| Enhabit (EHAB) | United States | $0.366B | 31.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.326B | 0.00 |
| LifeMD (LFMD) | United States | $0.241B | 0.00 |
| ModivCare (MODV) | United States | $0.223B | 12.09 |
| Sera Prognostics (SERA) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Biodesix (BDSX) | United States | $0.180B | 0.00 |
| Nutex Health (NUTX) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.100B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.25 |
| MultiPlan (MPLN) | United States | $0.084B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.043B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.08 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.020B | 0.00 |
| Oncology Institute (TOI) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |